Oxcarbazepine

Overview

Oxcarbazepine is an anticonvulsant and mood-stabilizing drug, used primarily in the treatment of epilepsy. It works by blocking sodium channels and stabilizing hyperexcited nerve cell membranes.

API suppliers (27)

Suppliers of Oxcarbazepine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• DASAMI LAB PRIVATE LTDIndia2 active DMF GMP on record
• ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
• AURORE LIFE SCIENCES PRIVATE LTD1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
• STHREE CHEMICALS PRIVATE LTD1 active DMF
• ARENE LIFE SCIENCES PRIVATE LTD1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
• JUBILANT BIOSYS LTDIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• ARCHIMICA SPAItaly1 active DMF GMP on record
• Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• SIGNA SA DE CV1 active DMF
• AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
• CTX LIFE SCIENCES PVT LTDIndia1 active DMF
• FIS FABBRICA ITALIANA SINTETICI SPAItaly1 active DMF GMP on record
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• Hubei Gedian Humanwell Pharmaceutical Co. LtdChina1 active DMF GMP on record
• CTX LIFESCIENCES PVT LTD
• BASF ORGAMOL PHARMA SOLUTIONS SA
• TRIFARMA SPAItaly GMP on record
• DR REDDYS LABORATORIES LTD GMP on record
• ERREDUE SPA INNOVATIVE CHEMICAL AND LIFE
• FABBRICA ITALIANA SINTETICI SPA
• MATRIX LABORATORIES LTD

Showing 25 of 27 suppliers — see the full list in the app.

EU CEP holders (11)

Companies holding a valid EU Certificate of Suitability (CEP) for Oxcarbazepine, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (58 approved US products), the latest listed US patent on Oxcarbazepine expires 13 Apr 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas